Valeant Pharmaceuticals (VRX) volatility spikes into Q3 and outlook

November 1, 2016 12:30 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Valeant Pharmaceuticals (VRX) 11/4 call option implied volatility is at 92, 11/11 s at 161; compared to its 52-week range of 53 to 173 into the expected release of Q3 results next week.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Options, Trader Talk

Related Entities


Add Your Comment